FDA’s Goodman Moving Up: Named Acting Chief Medical Officer, Appointed To CER Panel
This article was originally published in The Pink Sheet Daily
Executive Summary
CBER Deputy Director Midthun is now acting head of biologics center.
You may also be interested in...
CBER Director Midthun Retiring; Legacy Includes Biosimilar Principles, Avastin Withdrawal
While CBER is often perceived to be as much focused on research as it is on application review, Midthun was central to many key policy debates.
AHRQ’s Clancy, OMB’s Emanuel Among Key Figures On Comparative Research Committee
The 15-member council will oversee $1.1 billion in stimulus funding for comparative research. Clancy is only agency head included; OMB’s Ezekiel Emanuel likely to be key figure.
AHRQ’s Clancy, OMB’s Emanuel Among Key Figures On Comparative Research Committee
The 15-member council will oversee $1.1 billion in stimulus funding for comparative research. Clancy is only agency head included; OMB’s Ezekiel Emanuel likely to be key figure.